NEW YORK, March 6, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
The Outlook for Pharmaceuticals Worldwide
http://www.reportlinker.com/p0749910/The-Outlook-for-Pharmaceuticals-Worldwide .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical
Original, respected and reliable market reports that provide critical business insights to the prospects for, and risks in, leading pharmaceutical markets.
Espicom's Pharmaceutical Market Outlook reports have been used by senior management in commerce and industry for 30 years. Why? Because our experienced team of researchers and analysts combine economic, scientific, demographic and language skills to produce an unmatched and critical evaluation of the operating environment for pharmaceutical companies.
Original, respected and reliable market reports that provide critical business insights to the prospects for, and risks in, leading pharmaceutical markets.
Espicom's Pharmaceutical Market Outlook reports have been used by senior management in commerce and industry for 30 years. Why? Because our experienced team of researchers and analysts combine economic, scientific, demographic and language skills to produce an unmatched and critical evaluation of the operating environment for pharmaceutical companies.
An unmatched level of intelligence sourcing
Our full time team of experts regularly access over 1,200 primary source information points in regulatory authorities, health organisations, statistics offices and industry. Much of the information in the Pharmaceutical Market Outlook reports is not readily available in English elsewhere. Espicom partners with the widely regarded Economist Intelligence Unit (EIU) to provide up-to-date economic data – a constant requirement in these rapidly changing times.
Detailed analysis & novel forecasts
Assembling comprehensive data is one thing, but our strength lies in its interpretation. What does it mean and what are the implications for operations and business development? Our analysis is second to none and the economic and market forecasts are built on solid research principles and continually assessed to reflect current and anticipated market conditions.
Global Industry...
By 2016, the global pharmaceutical market, including pharmacy and hospital sales, is forecast to be worth around US$1.6 trillion at retail prices. High growth in emerging markets will leverage slow growth in developed markets. Cost-containment policies will be offset against market demands for more effective products. Health access will expand, due to increasing generic penetration.
Localisation
The local market is the operating environment in which companies have to work. Domestic priorities set the agenda that affects a company's operations, therefore the prevailing macroenvironment needs to be both understood and planned for. In this way, pharmaceutical companies have strengthened their capabilities to increase sales in local and international markets.
Beyond BRIC markets
The USA will continue to be the first worldwide economy, but other emerging markets will perform well, led by China, India, Russia and Brazil. However, a second wave of emerging markets will arise, namely South Korea, Mexico, Turkey, Indonesia and Poland. In an environment which is becoming more regulated, pharmaceutical producers are re-aligning their global strategies.
Quality information = business confidence
Any investment in market information must make a real return in terms of market knowledge and business efficiency. That demands the data is of the highest quality, thoroughly researched with primary sources and with insightful analysis and forecasts. Our team of analysts – with science, language and analysis skills – work full time to produce pharmaceutical market information that is second to none. With Pharmaceutical Market Outlook you get comprehensive market evaluation on which you can rely.
The Outlook for Pharmaceuticals in Central and Eastern Europe
Bulgaria
Croatia
Czech Republic
Hungary
Poland
Romania
Russia
Serbia
Slovakia
Slovenia
Ukraine
The Outlook for Pharmaceuticals in Northern Europe
Denmark
Estonia
Finland
Latvia
Lithuania
Norway
Sweden
The Outlook for Pharmaceuticals in Western Europe
Austria
Belgium
France
Germany
Ireland
Italy
The Netherlands
Portugal
Spain
Switzerland
UK
The Outlook for Pharmaceuticals in Central Asia
Bangladesh
China
India
Pakistan
The Outlook for Pharmaceuticals in South East Asia
Indonesia
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
The Outlook for Pharmaceuticals in North East Asia
China
Japan
South Korea
Taiwan
The Outlook for Pharmaceuticals in Latin America
Argentina
Brazil
Chile
Colombia
Cuba
Mexico
Peru
Venezuela
E7: The Outlook for Pharmaceuticals
Brazil
China
India
Indonesia
Mexico
Russia
Turkey
The Market for Pharmaceuticals in Brazil, Russia, India & China
Brazil
Russia
India
China
To order this report:
Pharmaceutical Industry: The Outlook for Pharmaceuticals Worldwide
Check our Industry Analysis and Insights
CONTACT
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article